Inhibition of cyclic AMP-dependent protein kinase in the acute phase of focal cerebral ischemia in the rat

Neuroscience

Volumn 94, Issue 2, 1999, Pages 361-371

  Tanaka, K ^a   Nogawa, S ^a   Nagata, E ^a   Suzuki, S ^a   Dembo, T ^a   Kosakai, A ^a   Fukuuchi, Y ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Cerebral ischemia; Cyclic AMP; Cyclic AMP dependent protein kinase; Focal ischemia; PKA; Signal transduction

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; BRAIN REGION; CONTROLLED STUDY; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; ANTIPYRINE; AUTORADIOGRAPHY; BRAIN; CARBON RADIOISOTOPES; CAUDATE NUCLEUS; CEREBRAL CORTEX; CEREBROVASCULAR CIRCULATION; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ISCHEMIC ATTACK, TRANSIENT; MALE; PUTAMEN; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW; REPERFUSION; TRITIUM;

EID: 0032835096     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00314-0     Document Type: Article

References (40)

1. Back T. Pathophysiology of the ischemic penumbra - revision of a concept. Cell. molec. Neurobiol. 18:1998;621-638.
2. Ballestas M.E., Benveniste E.N. Elevation of cyclic AMP levels in astrocytes antagonizes cytokine-induced adhesion molecule expression. J. Neurochem. 69:1997;1438-1448.
3. Bartus R.T., Dean R.L., Cavanaugh K., Eveleth D., Carriero D.L., Lynch G. Time-related neuronal changes following middle cerebral artery occlusion: implication for therapeutic intervention and the role of calpain. J. cerebr. Blood Flow Metab. 15:1995;969-979.
4. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17:1986;472-476.
5. Belayev L., Alonso O.F., Busto R., Zhao W., Ginsberg M.D. Middle cerebral artery occlusion in the rat by intraluminal suture. Stroke. 27:1996;1616-1623.
6. Cooper D.M., Mons N., Karpen J.W. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature. 374:1995;421-424.
7. 1 dopamine receptor binding in a rat model of focal cerebral ischemia. Brain Res. 577:1992;210-217.
8. Dawson-Saunders B. and Trapp R. G. (1994) Probability and related topics. In Basic and Clinical Biostatistics, pp. 64-81. Prentice-Hall International, London.
9. Dinerman J.L., Steiner J.P., Dawson T.M., Dawson V., Snyder S.H. Cyclic nucleotide dependent phosphorylation of neuronal nitric oxide synthase inhibits catalytic activity. Neuropharmacology. 33:1994;1245-1251.
10. Faux M.C., Scott J.D. More on target with protein phosphorylation: conferring specificity by location. Trends biochem. Sci. 21:1996;312-315.
11. Finkbeiner S., Tavazoie S.F., Maloratsky A., Jacobs K.M., Harris K.M., Greenberg M.E. CREB: a major mediator of neuronal neurotrophin responses. Neuron. 19:1997;1031-1047.
12. Gass P., Spranger M., Herdegen T., Bravo R., Kock P., Hacke W., Kiessling M. Induction of FOS and JUN proteins after focal ischemia in the rat: differential effect of the N-methyl-D-aspartate receptor antagonist MK-801. Acta neuropath. Berlin. 84:1992;545-553.
13. 3H]cyclic AMP: implications for organization of second messenger systems. Neuroscience. 29:1989;695-714.
14. Halpain S., Girault J.-A., Greengard P. Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices. Nature. 343:1990;369-372.
15. Hossmann K.-A. Periinfarct depolarizations. Cerebrovasc. Brain Metab. Rev. 8:1996;195-208.
16. Kohno K., Hoehn-Berlage M., Mies G., Back T., Hossmann K.-A. Relationship between diffusion-weighted MR images, cerebral blood flow, and energy state in experimental brain infarction. Magn. Reson. Imaging. 13:1995;73-80.
17. Koizumi J., Yoshida Y., Nakazawa T., Ooneda G. Experimental studies of ischemic brain edema. I. A new experimental model of cerebral embolism in rats in which recirculation can be introduced in the ischemic area. Jap. J. Stroke. 8:1986;1-8.
18. Ludvig N., Ribak C.E., Scott J.D., Rubin C.S. Immunocytochemical localization of the neural-specific regulatory subunit of the type II cyclic AMP-dependent protein kinase to postsynaptic strctures in the rat brain. Brain Res. 520:1990;90-102.
19. Lust W.D., Mrsulja B.B., Mrsulja B.J., Passonneau J.V., Klatzo I. Putative neurotransmitters and cyclic nucleotides in prolonged ischemia of the cerebral cortex. Brain Res. 98:1975;394-399.
20. Matsumoto K., Graf R., Rosner G., Taguchi J., Heiss W.-D. Elevation of neuroactive substances in the cortex of cats during prolonged focal ischemia. J. cerebr. Blood Flow Metab. 13:1993;586-594.
21. McKnight G.S. Cyclic AMP second messenger systems. Curr. Opin. Cell Biol. 3:1991;213-217.
22. Mies G., Ishimaru S., Xie Y., Seo K., Hossmann K.-A. Ischemic thresholds of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat. J. cerebr. Blood Flow Metab. 11:1991;753-761.
23. Mons N., Cooper D.M.F. Adenylate cyclases: critical foci in neuronal signaling. Trends Neurosci. 18:1995;536-542.
24. Montminy M.R., Gonzalez G.A., Yamamoto K.K. Regulation of cAMP-inducible genes by CREB. Trends Neurosci. 13:1990;184-188.
25. 23Na nuclear magnetic resonance spectroscopy. J. cerebr. Blood Flow Metab. 8:1988;16-23.
26. Nogawa S., Zhang F., Ross M.E., Iadecola C. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J. Neurosci. 17:1997;2746-2755.
27. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. 2nd edn. Academic, San Diego.
28. Pisano P., Samuel D., Nieoullon A., Kerkerian-LeGoff L. Activation of the adenylate cyclase-dependent protein kinase pathway increases high affinity glutamate uptake into rat striatal synaptosomes. Neuropharmacology. 35:1996;541-547.
29. Pulsinelli W.A. Selective neuronal vulnerability: morphological and molecular characteristics. Prog. Brain Res. 63:1985;29-37.
30. Rubino H.M., Dammerman M., Shafit-Zagardo B., Erlichman J. Localization and characterization of the binding site for the regulatory subunit of type II cAMP-dependent protein kinase on MAP2. Neuron. 3:1989;631-638.
31. 14C]antipyrine. Am. J. Physiol. 234:1978;H59-H66.
32. Sciancalepore M., Cherubini E. Protein kinase A-dependent increase in frequency of miniature GABAergic currents in rat CA3 hippocampal neurons. Neurosci. Lett. 187:1995;91-94.
33. Skalhegg B.S., Tasken K. Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA. Front. Biosci. 2:1997;d331-d342.
34. Supattapone S., Danoff S.K., Theibert A., Joseph S.K., Steiner J., Snyder S.H. Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium. Proc. natn. Acad. Sci. U.S.A. 85:1988;8747-8750.
35. Tanaka K., Gotoh F., Gomi S., Takashima S., Mihara B. Autoradiographic analysis on second-messenger systems and local cerebral blood flow in ischemic gerbil brain. J. cerebr. Blood Flow Metab. 11:1991;283-291.
36. Tanaka K., Fukuuchi Y., Gomi S., Takashima S., Mihara B., Shirai T., Nogawa S., Nozaki H., Nagata E., Kondo T. Flow threshold for enhanced phorbol ester binding in the ischemic gerbil brain. Neurochem. Res. 20:1996;1007-1012.
37. Tanaka K., Gomi S., Mihara B., Shirai T., Nogawa S., Nozaki H., Nagata E., Kondo T., Fukuuchi Y. Flow threshold for reduction of cyclic AMP binding in the hippocampus CA1 and other brain regions during stroke development in gerbils. J. cerebr. Blood Flow Metab. 16:1996;468-473.
38. Tanaka K., Fukuuchi Y., Nozaki H., Nagata E., Kondo T., Koyama S., Dembo T. Calcineurin inhibitor, FK506, prevents reduction in the binding capacity of cyclic AMP-dependent protein kinase in ischemic gerbil brain. J. cerebr. Blood Flow Metab. 17:1997;412-420.
39. Taylor S.S., Buechler J.A., Yonemoto W. cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes. A. Rev. Biochem. 59:1990;971-1005.
40. Walton M., Sirimanne E., Williams C., Gluckman P., Dragunow M. The role of the cyclic AMP-responsive element binding protein (CREB) in hypoxic-ischemic brain damage and repair. Molec. Brain Res. 43:1996;21-29.